2607.HK
2607.HK
CNE1000012B3
SH PHARMA
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 283.579.600.563 275.250.934.890
3.0%
Cost of Revenue 253.163.120.899 244.619.261.052
3.5%
Gross Profit 30.416.479.664 30.631.673.838
0.7%
21.133.323.509 20.941.761.555
0.9%
Operating Income 9.283.156.155 9.689.912.283
4.2%
Pretax Income 9.819.804.517 8.020.006.544
22.4%
Net Income Common Stockholders 5.724.557.508 4.552.528.439
25.7%
-- --
--
-- --
--
ende